Detalhe da pesquisa
1.
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
Hepatology
; 79(1): 49-60, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37870270
2.
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab.
Liver Int
; 43(3): 708-717, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36444741
3.
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC.
Liver Int
; 42(12): 2843-2854, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36254617
4.
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab.
Dig Liver Dis
; 2024 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38548580
5.
Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival.
Transplantation
; 107(2): 410-419, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36117256
6.
Complete response with sorafenib after immune-induced hepatitis with atezolizumab/bevacizumab for advanced hepatocellular carcinoma, synergic effect?
Clin Res Hepatol Gastroenterol
; 47(9): 102210, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37774919